Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Yaya Huashui
- ·The full record, as it builds
Funding rounds
No funding rounds for Yaya Huashui are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yaya Huashui
Developer of advanced drug discovery and development designed to deliver effective treatments for critical diseases. The company offers proprietary research capabilities and a wide range of medicines for chronic and life-threatening conditions, enabling healthcare professionals and patients to benefit from therapies that enhance quality of life and address significant medical gaps.
- Sector
- Healthcare
- HQ
- Tianjin, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Yaya Huashui doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yaya Huashui shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yaya Huashui in its N-PORT filings yet. We sweep new filings monthly.